4. ICH.M3 (R2): Non-clinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals. 2009

5. FDA. Guidance for industry and review staff: Recommended approaches to integration of genetic toxicology study results. 2006

6. OECD. Guideline for testing of chemicals No.471：Bacterial reverse mutation test.1997

7. OECD. Guideline for testing of chemicals No.473：InVitro mammalian chromosomal aberration test. 2016

8. OECD. Guideline for testing of chemicals No. 488：Transgenicrodent somatic and germ cell gene mutation assays. 2013

9. OECD. Guideline for testing of chemicals No. 489：Invivo mammalian alkaline comet assay. 2016

10. OECD. Guideline for testing of chemicals No. 490：Invitro mammalian cell gene mutation tests using the thymidine kinase gene. 2016

11. M7 评估和控制药物中 DNA 反应性（致突变）杂质以限制潜在的致癌风险.

12. M7(R1)：评估和控制药物中DNA反应性（致突变）杂质以限制潜在致癌风险.

13. 遗传毒性杂质的警示结构.CNKI

14. http://samr.cfda.gov.cn/WS01/CL0087/226424.html

15. 书籍：《毒理学》-毒物的基础科学

原标题：浅谈：从药理&毒理&警示结构，理解药物的基因毒问题！